AAAAAA

   
Results: 1-2 |
Results: 2
THERAPY OF STREPTOZOTOCIN-INDUCED DIABETES WITH A BIFUNCTIONAL ANTIBODY THAT DELIVERS VINCA ALKALOIDS TO IL-2 RECEPTOR-POSITIVE CELLS
Authors: KUUSREICHEL K KNOTT C SAMFONG P PETRELLA E CORVALAN JRF
Citation: K. Kuusreichel et al., THERAPY OF STREPTOZOTOCIN-INDUCED DIABETES WITH A BIFUNCTIONAL ANTIBODY THAT DELIVERS VINCA ALKALOIDS TO IL-2 RECEPTOR-POSITIVE CELLS, Autoimmunity, 22(3), 1995, pp. 173-181
PRODUCTION AND IN-VIVO CHARACTERIZATION OF A BIFUNCTIONAL ANTIBODY (IVA039.1) WITH SPECIFICITY FOR THE MOUSE INTERLEUKIN-2 RECEPTOR AND VINCA ALKALOIDS
Authors: KUUSREICHEL K KNOTT CL SAMFONG P JUE RA MACKENSEN DG CORVALAN JRF
Citation: K. Kuusreichel et al., PRODUCTION AND IN-VIVO CHARACTERIZATION OF A BIFUNCTIONAL ANTIBODY (IVA039.1) WITH SPECIFICITY FOR THE MOUSE INTERLEUKIN-2 RECEPTOR AND VINCA ALKALOIDS, Hybridoma, 13(2), 1994, pp. 115-122
Risultati: 1-2 |